2002 Vol.20, N°5 - Suppl.27 - Table of contents
Title: IL-1Ra as a new biological approach for the treatment of rheumatoid arthritis.
Page 1
| Page | Article - [Author(s)] | Abs. | CME | Audio | Media | |
|---|---|---|---|---|---|---|
| Full Paper | ||||||
| CER1378 2002,20,5,Suppl.27 Pg. 0001-0013 | The IL-1 family and inflammatory diseases C.A. Dinarello › Free to View |  |  | |||
| Introduction | ||||||
| CER1377 2002,20,5,Suppl.27 Pg. 0001 | Introduction M. Cutolo, B. Bresnihan, J.M. Dayer › Free to View | | | |||
| Full Paper | ||||||
| CER1379 2002,20,5,Suppl.27 Pg. 0014-0020 | Evidence for the biological modulation of IL-1 activity: The role of IL-1Ra J.M. Dayer › Free to View | | | |||
| CER1380 2002,20,5,Suppl.27 Pg. 0021-0025 | Is there a rationale for combined TNF and IL-1 blocking in arthritis ? W.B. van den Berg › Free to View | | | |||
| CER1381 2002,20,5,Suppl.27 Pg. 0026-0031 | Effects of DMARDs on IL-Ra levels in rheumatoid arthritis: Is there any evidence ? M. Cutolo › Free to View | | | |||
| CER1382 2002,20,5,Suppl.27 Pg. 0032-0034 | Anakinra as a new therapeutic option in rheumatoid arthritis: Clinical results and perspectives B. Bresnihan › Free to View | | | |||
| CER1383 2002,20,5,Suppl.27 Pg. 0035-0041 | Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-α agents R.M. Fleishmann › Free to View | | | |||
| CER1384 2002,20,5,Suppl.27 Pg. 0042-0047 | Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: Evidence from longitudinal observations over 5-20 years T. Pincus, T. Sokka › Free to View | | | |||
Page 1
